All articles by Anthony King – Page 13
-
BusinessReckitt Benckiser to buy into baby milk
$17bn acquisition of Mead Johnson expands presence in developing markets, especially China
-
NewsNew database offers one stop shop for food safety hazards
Tool brings together safety information from Europe’s food safety agency
-
BusinessOpening doors to innovation
Chemical companies are increasingly using specialist investment arms to nurture new ideas
-
BusinessTaming vaccines with chemistry
Vaxxilon aims to simplify vaccine development by replacing biological components with well-defined synthetic molecules
-
ResearchStrongest synthetic spider silk spun-out in the lab
Mimicking spiders’ spinning glands could cut cost of synthetic silk
-
NewsFears that gene-editing cancer trials are premature
Warnings from geneticists that Crispr trial failures could knock promising technique’s prospects
-
NewsSwiss immigration compromise puts EU science back on the menu
Agreement to allow free movement will see Switzerland return to being a full member of the Horizon 2020 science programme
-
FeatureLab automation
Automated tools can take the drudgery out of routine lab work, Anthony King reports
-
ResearchAtmospheric limestone dust injection could halt global warming
Geoengineering using limestone aerosols would also help to stop ozone layer depletion
-
ResearchElectron microscope captures cells in colour for the first time
Breakthrough technique allows specific cell proteins to be visualised at high resolution using EM
-
ResearchGooey origins for RNA world
Viscous muddy pond edges may have been incubators for the rise of self-replicating RNAs on ancient Earth
-
FeatureNew MRI contrast agents
With rising concerns over gadolinium, Anthony King looks at the alternatives under development
-
NewsPharma giants commit to tackling antimicrobial resistance
Plan to tackle superbugs includes changes to manufacturing and sales incentives
-
BusinessBayer to buy seed giant Monsanto
$66bn deal follows agrochemical consolidation trend, but could threaten competition and hit R&D
-
BusinessSadara cracker eyes richer chemical rewards
Joint venture between Dow and Saudi Aramco will target added value plastics and speciality chemicals
-
NewsBrexit referendum storm shakes European Research Council
Europe’s premier science council’s mission at risk with the impending loss of two scientific powerhouses
-
NewsAntibiotic partnership plans accelerated drug development
Public–private venture will invest $350 million over five years but there are warnings that much more money is still needed
-
NewsReport takes aim at research assessment’s cost and distortions
Head of British Academy recommends more flexibility for the Research Excellence Framework to end ‘gaming’ of the exercise
-
ResearchNew antibiotic picked from nose bacteria
Discovery suggests human microbiome may be an untapped source of antimicrobial compounds
-
ResearchKamikaze bacteria travel deep inside tumours to deliver deadly cargo
Engineered bacteria in tandem with chemotherapy show promise in mouse model of cancer